Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach

NCT01422902 is registered in ClinicalTrials.gov with Posit Science Corporation as lead sponsor.

NCT NCT01422902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01422902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults, A Remediation-based Approach
Lead sponsor
Posit Science Corporation
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
June 30, 2015
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia